Platelet mapping as part of modified thromboelastography (TEG®) in patients undergoing cardiac surgery and cardiopulmonary bypass (Q48145829)

9 February 2018

title

Platelet mapping as part of modified thromboelastography (TEG®) in patients undergoing cardiac surgery and cardiopulmonary bypass (English)

1 reference

9 February 2018

author

Zung V Tran

5

1 reference

9 February 2018

author name string

N S Weitzel

1

1 reference

9 February 2018

L B Weitzel

2

1 reference

9 February 2018

L E Epperson

3

1 reference

9 February 2018

A Karimpour-Ford

4

1 reference

9 February 2018

T Seres

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

18 July 2012

1 reference

9 February 2018

published in

Anaesthesia

1 reference

9 February 2018

volume

67

1 reference

9 February 2018

issue

10

1 reference

9 February 2018

page(s)

1158-1165

1 reference

9 February 2018

Variability and predictability of large-volume red blood cell transfusion in cardiac surgery: a multicenter study.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Platelet transfusion in cardiac surgery does not confer increased risk for adverse morbid outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Side effects of cardiopulmonary bypass: what is the reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleedin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

The laboratory evaluation of platelet dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

A Thrombelastograph whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

The independent association of massive blood loss with mortality in cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Near-patient platelet function testing in patients undergoing coronary artery surgery: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Platelet receptors and signaling in the dynamics of thrombus formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Influence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2012.07231.X

10.1111/J.1365-2044.2012.07231.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018